Navigation Links
Access Pharmaceuticals Presents ProLindac(TM) Data at the AACR-NCI-EORTC Symposium 2008
Date:10/21/2008

- ProLindac Is Safe And Active in Recurrent Ovarian Cancer; Unique Design Simulates 4-Day Continuous Infusion -

DALLAS, Oct. 21 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that three posters describing significant recent results of the company's proprietary polymer DACH platinum prodrug, ProLindac, in clinical and preclinical studies are being presented this week at a major international oncology conference held in Geneva, Switzerland.

The clinical poster highlights results from the multi-center Phase 2 recurrent ovarian cancer trial in France where the level of anti-cancer activity of ProLindac in a heavily-pretreated patient population compares favorably to previously published results of single agent oxaliplatin in patients that had less pretreatment. These promising efficacy results were obtained without significant toxicity or other significant side-effects. The two preclinical posters, describing studies performed by Access collaborators at prominent Institutes in France, demonstrate the potential benefits of ProLindac over current platinum therapies: one highlights the observation that ProLindac uses albumin as a carrier, slowing blood clearance, which provides for a sustained tumor exposure to platinum. The other poster highlights that the antiproliferative effects of ProLindac are associated with an increase in expression of p21, a gene associated with cell cycle control.

"The latest results from our clinical study in advanced ovarian cancer patients continue to demonstrate that ProLindac is active in ovarian cancer with mild side-effects," stated David P. Nowotnik, Access' Senior Vice President Research and Development. "The two preclinical posters show that, mechanistically, ProLindac is similar to the approved DACH platinum compound, oxaliplatin, while benefiting from Access' proprietary polymer targeting technology. Our unique design enables targeted delivery of higher lev
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Bend Research Offers Broad Access to Drug-Delivery Solutions
2. Concentric Medical Launches Distal Access Catheter
3. Bumrungrad International Hospital Makes Treatment Costs Available to Public - Bumrungrad International Offers Free Online Access to Actual Costs of 45 Procedures
4. Access to Physicians Is Consumers Highest Priority When Choosing a Health Plan, According to New Study
5. SAGE-Hindawi launch new open-access journal in dental biomechanics
6. Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers
7. ICERx.org Activated to Provide Emergency Access to Prescription Medication Information for Hurricane Ike Evacuees
8. New Vascular Access Medical Devices Launched by Navilyst Medical
9. Gulf Coast Dialysis Caregivers, Volunteers Brace for Hurricane Ike; Prepare to Maintain Power, Continued Access for Patients to Life-Saving Treatment
10. Young African-American Males Face Mental Health Crisis; Experts Call For New Treatment Strategies and Better Access to Care
11. Autovan Donates Wheelchair-Accessible Van; Brings Greater Mobility to Facility in Rochester, New York

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... XenaCare Holdings has an...he Arthritis Foundation, one of the largest nonpro...and public health education. , ...- XenaCare Holdings, Inc. (OTCBB: XCHO), a company...tion of consumer healthcare products, has announce...
(Date:11/27/2009)... Voyant Health™ ann...ichigan) has licensed its TraumaCad Enterprise ort...nd workflow solution. , (...nnounced today that Spectrum Health (Grand Rapids,...rthopedic templating solution and its TraumaCad Ex...
(Date:11/26/2009)..., , NEW YORK, Nov. 27 With...than ever to employ good practices to control the ...need to be proactive not only to keep ourselves he...sick," said Eileen Finerty, RN, MS, CIC (certified...tion control and occupational health at Hospital f...
(Date:11/26/2009)...Luggage that,s too big or too heavy can lead to st...althDay News) -- There may be nothing wrong with s...t not want to do the same thing with your suitcase...000 people were treated in 2008 in U.S. hospital e...r medical facilities for luggage-related injuries,...
(Date:11/26/2009)... Research Triangle Dental...ntral North Carolina, today announced the expansio...ied LUMINEER Dentist, Dr. Doug Macmillan. , ...ch Triangle Dental is pleased to announce that Dr....t, recently completed an additional advanced train...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...es in Northeast, government reports , , WE... rate in the United States increased in 26 of the ...n of the country, according to a new government re...sed for the first time in 15 years in 2006 -- from...
...c., a leader in,software-driven systems for target...ew, customer-focused sales and support structured ...wth and an expanding product,portfolio. , By i...ities, communication, reporting structures will en...
...se, an internationally recognized inpatient treatm...xpanding their patient care programs in 2009. The ...se is promoting the message that recovery from add...lic at large in an effort to reduce the stigma ass...
...olution emerges when,technology blends with smart ...with its new Smart OR(TM) - a specialized neurosur...or neurosurgery, spine and trauma patients. , ...neurosurgeons perform complex brain, spine and tra...
...atory Plans for Cutting-Edge Technology at Nationa... , WASHINGTON, Jan. 7 Nanotechnology was incorpo...oods last year. By 2014, the market will grow to $...s project that nanotechnology will be incorporated...
...pany,(NYSE: LLY ) will announce its financial re... on Thursday, January 29, 2009. Lilly will also c...stment community and media to further,detail the c...ccess a live webcast of the,conference call throug...
Other Medicine News:Health News:Teen Birth Rate Up in 26 States in 2006 2Health News:BrainLAB, Inc. Announces New, Streamlined Surgery Business Division 2Health News:Seabrook House Embraces the New Year with New Programs 2Health News:Seabrook House Embraces the New Year with New Programs 3Health News:A New, 'Smart' Approach to Brain and Spine Surgery 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 2Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 4
(Date:11/25/2009)...PRNewswire/ -- Swissray International, Inc. a lead...dR ) systems, announced today that its operations ...h a long term view towards growing Swissray,s medi...sets and intellectual property, as well as contrac...owth Swissray is now poised to move to the next le...
(Date:11/25/2009)...e/ -- Reportlinker.com announces that a new market..., Pain Management - Global Trends ,, htt...--Global-Trends.html ,, Widespread availabilit...linics, and the advent of new drugs have accelerat...t. Healthcare reforms and reimbursement structure ...
(Date:11/25/2009)...ewswire/ -- ChemoCentryx, Inc., announced today ... PROTECT-1 (the Prospective Randomized Oral Therap...-EN(TM) (CCX282-B) in patients with moderate-to-se...y with a favorable safety and tolerability profile...icacy in the reduction of disease severity as defi...
Breaking Medicine Technology:Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Disease threat may change how frogs mate 9368 1Disease threat may change how frogs mate 9368 2Scientists track impact of DNA damage in the developing brain 9364 1Scientists track impact of DNA damage in the developing brain 9364 2Scientists track impact of DNA damage in the developing brain 9364 3Association of Gaming Equipment Manufacturers 28AGEM 29 Announces 24100 000 in Contributions to Organizations Working to Assist Problem Gamblers 52789 1Association of Gaming Equipment Manufacturers 28AGEM 29 Announces 24100 000 in Contributions to Organizations Working to Assist Problem Gamblers 52789 2Association of Gaming Equipment Manufacturers 28AGEM 29 Announces 24100 000 in Contributions to Organizations Working to Assist Problem Gamblers 52789 3
...om the U.S. Preventive Services Task Force (USPSTF...preventing heart attacks and strokes among many ad...today. , , The USPSTF found that regular aspirin ...trokes in women. The recommendation applies to me... 79. Aspirin should be used when the benefits out...
...Time - , , SOUTH SAN FRANCISCO, Calif., March 16... a biopharmaceutical company focused on oncology, ...arter and year ended December 31, 2008, and provid...arter of 2008, we made significant progress toward...platform compound by advancing our pivotal Phase 3...
Other Medicine Technology:New Aspirin Recommendation Can Help Prevent Heart Attacks & Strokes, Says Partnership for Prevention 2Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 7Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 8Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 9
EndoProbe Handpieces
...custom assay service that develops assays for labo...ssay of interest, the customer simply provides the...l provide a protocol and a Field Applications Spec...laboratory. This will help reduce labor costs and ...
...ition is designed for all physicians, residents, a...s. It provides speedy access via your handheld dev...ermine whether imaging examinations are necessary,...e the most information. The content includes curre...
Perkins Hand Held Applanation Tonometer
Medicine Products: